Amherst receives grant funds to protect town drinking water
The Healey administration announced on Friday that the Executive Office of Energy and Environmental Affairs (EEA) will provide over $1 million in grant funding to protect drinking water resources in the state. Five cities and towns were selected to receive funds, allowing these communities to purchase land to maintain the safety and quality of drinking water for residents.
Two Springfield golf courses receive $6M in clubhouse upgrades
'This funding is a critical step in ensuring that our communities have access to safe, clean drinking water,' said EEA Secretary Rebecca Tepper. 'By investing in land protection, we are not only safeguarding our vital water resources but also enhancing the quality of life for residents who rely on these resources for health and recreation.'
All land secured through funds from the Drinking Water Supply Protection Program will be designated protected open space under Article 97 of the Massachusetts Constitution. The town of Amherst was awarded $218,820 in grant funds to purchase an over 50-acre wooded property in Pelham.
The purchase of this property, adjacent to designated Watershed Protection Land, will protect designated Zone A surface water that contributes to the Pelham Reservoir System. Approximately one-third of Amherst's drinking water comes from the reservoir system, and it will now receive greater protection and directly benefit public health.
Other communities receiving grant funds through the program are Haverhill, Falmouth, Amesbury, and Cambridge.
WWLP-22News, an NBC affiliate, began broadcasting in March 1953 to provide local news, network, syndicated, and local programming to western Massachusetts. Watch the 22News Digital Edition weekdays at 4 p.m. on WWLP.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Jefferies Reiterates a Buy Rating on Boston Scientific Corporation (BSX), Sets a $130 PT
Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in for beginners. In a report released on August 11, Matthew Taylor from Jefferies reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) with a price target of $130.00. A surgeon examining a patient's brain in an operating room, paramedics nearby. The rating update followed the company's release of fiscal Q2 2025 earnings on July 23, with net sales for the quarter reaching $5.061 billion and reflecting a 22.8% growth on a reported basis, 21.6% on an operational basis, and 17.4% on an organic basis, all compared to the prior year period. Boston Scientific Corporation (NYSE:BSX) also reported GAAP net income attributable to common stockholders of $797 million or $0.53 per share (EPS), compared to $324 million or $0.22 per share a year ago. Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
a day ago
- Yahoo
FDA Monitors Safety Issue with Boston Scientific Defibrillator Leads
Boston Scientific Corporation (NYSE:BSX) is one of the best high-volume stocks to invest in. On August 6, the FDA announced that it is monitoring a safety issue with Boston Scientific Corporation's ENDOTAK RELIANCE defibrillation leads, which are used with implantable cardioverter-defibrillators to prevent sudden cardiac death. Earlier this year, the company sent a letter to healthcare providers on July 24, warning that calcification of the leads' expanded polytetrafluoroethylene/ePTFE coating could lead to a gradual increase in low-voltage shock impedance/LVSI. This can reduce the effectiveness of life-saving shocks and even result in patient death. A surgeon examining a patient's brain in an operating room, paramedics nearby. The affected leads were manufactured and distributed between 2002 and 2021 and are no longer available. As of July 24, Boston Scientific had reported 386 serious injuries and 16 deaths linked to this issue. The FDA has categorized this as a potentially high-risk problem and is actively reviewing data to determine further regulatory action. Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It has 2 segments: MedSurg and Cardiovascular. While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Aimco sells 5 Boston properties for $740M
This story was originally published on Multifamily Dive. To receive daily news and insights, subscribe to our free daily Multifamily Dive newsletter. In January 2025, Aimco's board of directors decided to explore alternatives to 'unlock and maximize shareholder value' for the Denver-based REIT. Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership Aimco took one step in that direction earlier this month with the sale of a portfolio of five suburban Boston-area properties in Massachusetts, New Hampshire and Rhode Island, totaling 2,719 units, to an affiliate of Harbor Group International for $740 million, according to a news release. HGI completed due diligence and made a $20 million nonrefundable deposit. Four of the five asset sales are expected to close during the third quarter of this year, while the final one is anticipated to close in the fourth quarter. 'The agreement to sell our suburban Boston portfolio represents another important step in our ongoing commitment to maximize and unlock value for Aimco shareholders,' company President and CEO Wes Powell said in the news release. The five properties were built between 1970 and 1974, according to a news release from Harbor Group. Their unit interiors feature stainless steel appliances and hardwood flooring. Amenities across the properties include swimming pools, fitness centers, clubhouses and community green spaces. As of July 2025, the portfolio was 95.7% occupied. Historical occupancy has averaged 97% since 2022. "The addition of these communities will deepen HGI's presence within the Boston area, a market exhibiting robust multifamily fundamentals where we already have a strong operating footprint," said Yisroel Berg, chief investment officer of multifamily at HGI in Harbor Group's news release. Aimco's next moves Aimco remains on track to sell its Brickell Assemblage, which includes The Yacht Club Apartments and the adjacent 1001 Brickell Bay Drive office building, located in Miami, for $520 million, as announced in January. During July, the buyer exercised its final closing extension option and increased its nonrefundable deposit by $7 million, bringing the total to $50 million. Closing is now scheduled for the fourth quarter of 2025. Aimco expects to gain $1.26 billion in gross proceeds from the Boston and Brickell transactions. When accounting for associated property-level debt and the deferred tax liability related to the Brickell assets, net proceeds should be approximately $785 million, or $5.21 per common share. Following the sales in Boston and Miami, Aimco's remaining portfolio will comprise 18 apartment communities, containing 3,457 units. Those properties are concentrated in suburban Chicago and the Washington, D.C., metro area. The REIT also has three lease-up properties slated to be fully stabilized at the end of 2026. Aimco is also developing a waterfront residential tower in Miami, which is on schedule for delivery in 2027, and a controlled development pipeline containing the potential for more than 3,700 new apartment homes, according to the news release. Even after the Boston and Miami sales, Aimco will continue to explore further ways to maximize and unlock shareholder value through additional strategic transactions. Those could include the sale of additional components of the portfolio, individual asset sales or a sale or merger of the company. Morgan Stanley & Co. is serving as the REIT's financial advisor through the process. Aimco spun off from Denver-based Apartment Income REIT Corp. in December 2020. Last April, AIR and New York City-based investment manager Blackstone announced they had entered into an agreement for Blackstone Real Estate Partners X to acquire all outstanding common shares of AIR for approximately $10 billion, including the assumption of debt. Click here to sign up to receive multifamily and apartment news like this article in your inbox every weekday. Recommended Reading Fogelman makes a purchase near the University of Georgia Sign in to access your portfolio
